MYC and breast carcinoma: The above bioinformatic analysis identified that cuproptosis predicted poor clinical outcomes of patients with breast cancer, and suggested that this pro-tumoral effect was significantly associated with c-Myc-mediated downstream targets, we inferred that cuproptosis engaged in c-Myc-mediated tumor progression.